Cardiovascular Diseases Research in Iowa
Cardiovascular Diseases Research (93.837) awarded $137 million to recipients in Iowa in 112 grants from fiscal 2021 to 2025, 0.9% of the program's national total. The University of Iowa received the most, $128 million.
- Awarded in Iowa$137 million
- Awards112
- Share of the program0.9%
- Rank among states25th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 48 | $25.6 million |
| FY 2022 | 44 | $23.9 million |
| FY 2023 | 53 | $27.2 million |
| FY 2024 | 53 | $27.2 million |
| FY 2025 | 61 | $33.5 million |
Recipients in Iowa
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The University of Iowa | Colleges and universities | 104 | $128 million |
| Iowa State University of Science and Technology | Colleges and universities | 3 | $3.6 million |
| Mti Biotech, Incorporated | Small businesses | 2 | $3.3 million |
| Pranions, Inc. | Small businesses | 1 | $1.2 million |
| Des Moines University Osteopathic Medical Center | Colleges and universities | 2 | $899,397 |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Iowa?
$137 million from fiscal 2021 to 2025, across 112 awards. Iowa ranks 25th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Iowa?
The largest recipient is The University of Iowa, with $128 million in 104 awards. Next are Iowa State University of Science and Technology and Mti Biotech, Incorporated.
Can organizations in Iowa apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Iowa
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- Child Care and Development Block Grant
- Special Education Grants to States
- Temporary Assistance for Needy Families
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Title I Grants to Local Educational Agencies